Peer review reports
From: Interleukin-6 mediates resistance to PI3K-pathway–targeted therapy in lymphoma
Original Submission | ||
---|---|---|
22 Mar 2019 | Submitted | Original manuscript |
20 May 2019 | Reviewed | Reviewer Report - Jui-Chieh Chen |
29 May 2019 | Reviewed | Reviewer Report - Basudev Chowdhury |
30 Jul 2019 | Author responded | Author comments - Joo Hyun Kim |
Resubmission - Version 2 | ||
30 Jul 2019 | Submitted | Manuscript version 2 |
13 Aug 2019 | Author responded | Author comments - Joo Hyun Kim |
Resubmission - Version 3 | ||
13 Aug 2019 | Submitted | Manuscript version 3 |
Publishing | ||
19 Aug 2019 | Editorially accepted | |
10 Oct 2019 | Article published | 10.1186/s12885-019-6057-7 |